SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Tuesday, May 13, 2008 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

PRIME NEWS
TaiGen announces positive data from Phase II study of Nemonoxacin
TaiGen Biotechnology, a leading development stage pharmaceutical company based in Taiwan announced that the nemonoxacin phase II top-line data in community-acquired pneumonia met the primary endpoint of non-inferiority versus levofloxacin
TaiGen initiates Phase I trial of stem cell mobilizer TG-0054
TaiGen Biotechnology, a leading development stage pharmaceutical company based in Taiwan announced the enrollment for the TG-0054 phase I trial under an IND from the US FDA
TODAY'S NEWS
  Aurobindo Pharma to market 9 products in South Africa
  Spectrum Pharma sells injectable generic drugs to Sagent Pharma
  Merck, Schering-Plough present results of cholesterol drug
  Ranbaxy, Merck sign drug discovery, development agreement
  Over 1200 firms attend API & INTERPHEX China
  Helicon group secures China rights For Collatamp G
Advertisement
 
Digital Mag
Updated Fortnightly

Issue: April 30, 2008
Current Issue
View / Download
Top Story
China steps up the pace: India and China are racing to become lucrative pharmaceutical markets for global players
 
 
 
Print Edition
Issue: May 2008
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement





















 

NEWS
ITRI, NTU Hospital license ACRT to Exactech Taiwan
The Industrial Technology Research Institute (ITRI) and National Taiwan University (NTU) Hospital which have co-developed biphasic osteochondral repair for articular cartilage regeneration technology announced licensing agreement with Exactech Taiwan
CytoGenix signs agreement with Taiwan Cobia to develop DNA vaccines
CytoGenix, a Houston-based biopharmaceutical company announced it has completed an agreement with Taiwan Cobia Inc. (TCI), the first company to introduce the concept of Organic Aqua Farming in Taiwan, to develop DNA vaccines against fish viruses
FEATURES
Ready for translational medicine age
The National Taiwan University College of Medicine tackles the challenge of expeditiously moving basic research findings from bench to bedside
A benchmark for biosciences research
Taiwan's Biomedical Engineering Laboratory (BEL), an arm of the Industrial Technology Research Institute (ITRI), is a not-for-profit application-oriented technology research powerhouse that focuses on pioneering research
PEOPLE
Dr. Chung-Cheng Liu takes over as VP & GD, BEL -Taiwan
A premier-selection council of Industrial Technology Research Institutes in Taiwan has appointed former Deputy General Director of Biomedical Engineering Research Laboratories, Dr. Chung-Cheng Liu to the position of VP and General Director of BEL
TaiGen names Dr Hsu as new Chairman
TaiGen Biotechnology has elected Dr Ming Chu Hsu as the Chairman of the company
EVENTS
Taiwan to develop $900 mn biotech park
The government in Taiwan is keen to establish biotech parks with unique features.
Taiwan to develop $900 million national biotech park
The Taiwan Ministry of National Defense has decided to make available 25 hectares of its property at the Military 202 Armament Factory in Nankang for the establishment of a biotech science park
R & D
TaiGen announces positive data from Phase II study of Nemonoxacin
TaiGen Biotechnology, a leading development stage pharmaceutical company based in Taiwan announced that the nemonoxacin phase II top-line data in community-acquired pneumonia met the primary endpoint of non-inferiority versus levofloxacin
TaiGen initiates Phase I trial of stem cell mobilizer TG-0054
TaiGen Biotechnology, a leading development stage pharmaceutical company based in Taiwan announced the enrollment for the TG-0054 phase I trial under an IND from the US FDA
POLICIES
Taiwan government revamps pharma regulations
Taiwan's Science and Technology Advisory Board has implemented key changes in the drug regulations to increase foreign pharmaceutical and biotechnology companies foray into Taiwan
EU approves OculusGen biodegradable collagen matrix
OculusGen Biodegradable Collagen Matrix, developed in Taiwan, has received EUs CE Mark approval and the Canadian CMDCAS Certification for implantation in ophthalmic surgeries
PRODUCTS
Tercica’s Increlex to be sold in Taiwan and Gulf Countries
Tercica has signed distribution agreements with Biologix and Giddi Pharma to distribute Increlex in Middle East, North African countries and Taiwan
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black